Page 246 - Liver Diseases in Children
P. 246

236      โรคตับในเด็ก




              pthaigastro.org
            เอกสำรอ้ำงอิง

            1.  Ebel NH, Murray KF. Drug-induced liver disease. In: Kelly DA, editor. Diseases of the liver and biliary
               system in children. 4th ed. West Sussex: John Wiley & Sons Ltd; 2017. p. 169-90.
            2.  Molleston JP, Fontana RJ, Lopez MJ, Kleiner DE, Gu J, Chalasani N. Characteristics of idiosyncratic
               drug-induced liver injury in children: results from the DILIN prospective study. J Pediatr Gastroenterol
               Nutr 2011;53:182-9.
            3.  Amin MD, Harpavat S, Leung DH. Drug-induced liver injury in children. Curr Opin Pediatr 2015;27:625-33.
            4.  Kumar A, Sood V, Khanna R, Verma SK, Mehra N, Rawat D, et al. Clinical spectrum and outcome of
               pediatric drug induced liver injury. Indian J Pediatr 2017 Dec 16.
            5.  Shi Q, Yang X, Greenhaw JJ, Salminen AT, Russotti GM, Salminen WF. Drug-induced liver injury in
               children: clinical observations, animal models, and regulatory status. Int J Toxicol 2017;36:365-79.

            6.  Ferrajolo C, Capuano A, Verhamme KM, Schuemie M, Rossi F, Stricker BH, et al. Drug-induced hepatic
               injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase. Br J Clin
               Pharmacol 2010;70:721-8.
            7.  Devarbhavi H, Karanth D, Prasanna KS, Adarsh CK, Patil M. Drug-induced liver injury with hypersensitivity
               features has a better outcome: a single-center experience of 39 children and adolescents. Hepatology
               2011;54:1344-50.
            8.  Zhu Y, Li YG, Wang JB, Liu SH, Wang LF, Zhao YL, et al. Causes, features, and outcomes of drug-induced
               liver injury in 69 children from China. Gut Liver 2015;9:525-33.
            9.  Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol

               Ther 2008;118:250-67.
            10.  Kopylov U, Amre D, Theoret Y, Deslandres C, Seidman EG. Thiopurine metabolite ratios for monitoring
               therapy in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2014;59:511-5.
            11.  Fontana RJ, Seeff LB, Andrade RJ, Bjornsson E, Day CP, Serrano J, et al. Standardization of nomenclature
               and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology
               2010;52:730-42.
            12.  Murray KF, Hadzic N, Wirth S, Bassett M, Kelly D. Drug-related hepatotoxicity and acute liver failure.
               J Pediatr Gastroenterol Nutr 2008;47:395-405.
            13.  ศรีศุภลักษณ์ สิงคาลวณิช, จรูญ เจตศรีสุภาพ, จุฬาภรณ์ พฤกษชาติคุณากร, ชมนาด นวลปลอด, เทอดพงศ์ เต็มภาคย์,
                                                              ิ
               ปาจรีย์ ณิยกูล, มนตรี อุดมเพทายกุล, รัตนาวลัย จันทร, วนิดา ล้มพงศานุรักษ์, วาณี วิสุทธ์เสรีวงศ์, ศิริวรรณ วนานุกูล,
                                                                                 ิ
               สุชีรา ฉัตรเพรดพราย, อมรศรี ชุณหรัศมิ์. แนวทางการดูแลรักษากลุ่มอาการ drug hypersensitivity syndrome
               2559. Available from: http://www.thaipediatrics.org/Media/media-20161130141430.pdf
            14.  Squires RH, Jr., Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver
               failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr
               2006;148:652-8.
   241   242   243   244   245   246   247   248   249   250   251